Background: Repetitive transcranial magnetic stimulation (rTMS) is one of the high-potential non-pharmacological methods for migraine treatment. The purpose of this study is to define the neuroimaging markers associated with rTMS therapy in patients with migraine based on data from functional MRI (fMRI). Materials and Methods: A total of 19 patients with episodic migraine without aura underwent a 5-day course of rTMS of the fronto-temporo-parietal junction bilaterally, at 10 Hz frequency and 60% of motor threshold response of 900 pulses. Resting-state functional MRI (1.5 T) and a battery of tests were carried out for each patient to clarify their diagnosis, qualitative and quantitative characteristics of pain, and associated affective symptoms. Changes in functional connectivity (FC) in the brain's neural networks before and after the treatment were identified through independent components analysis. Results: Over the course of therapy, we observed an increase in FC of the default mode network within it, with pain system components and with structures of the visual network. We also noted a decrease in FC of the salience network with sensorimotor and visual networks, as well as an increase in FC of the visual network. Besides, we identified 5 patients who did not have a positive response to one rTMS course after the first week of treatment according to the clinical scales results, presumably because of an increasing trend of depressive symptoms and neuroimaging criteria for depressive disorder. Conclusions: Our results show that a 5-day course of rTMS significantly alters the connectivity of brain networks associated with pain and antinociceptive brain systems in about 70% of cases, which may shed light on the neural mechanisms underlying migraine treatment with rTMS.
19 July 2023 in V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY
Bipolar affective disorder (BD) is a complex mental illness that presents diagnostic challenges due to its heterogeneous nature. As a result, identifying potential markers for the disorder is crucial for effective diagnosis and treatment. Resting-state functional magnetic resonance imaging (rs-fMRI) is a promising non-invasive technique that provides a window into the pathophysiological characteristics of psychiatric and neurological diseases in vivo. The amount of data accumulated in the scientific community regarding changes in spontaneous activity and functional connectivity of brain regions in BD necessitates a comprehensive synthesis to determine the spectrum of disorders. Accordingly, a systematic review of reviews was conducted to summarize the changes characteristic of patients with BD as measured by fMRI. Qualitative synthesis of results of nine systematic reviews and six meta-analyses has allowed the definition of changes in spontaneous activity and functional connectivity most characteristic for BD, confirming the unity of functional disturbances of this nosological unit. The findings of the review indicate that the manic state in BD is often associated with increased activity of the amygdala and decreased functional connectivity between the amygdala and frontal regions. Conversely, the depressive phase is characterized by abnormalities of functional connectivity within the default mode network, particularly in relation to the posterior cingulate cortex. Changes in functional connectivity during periods of euthymia may reflect residual manifestations of one of the exacerbation phases or may be associated with a history of a psychotic episode. Furthermore, a comparative analysis of possible methods of quantitative fMRI data synthesis has been conducted for the first time in Russia, which is a valuable contribution to the field.
BACKGROUND. Hypnotherapy is one of the treatments for irritable bowel syndrome (IBS). AIM. Meta-analysis was to evaluate the effectiveness of its use and to identify the most optimal conditions for its implementation. MATERIALS AND METHODS. We analyzed Scientific medical databases PubMed, EMBASE, eLibrary for the period from 2005 to 2022. Studies performed on adult samples of patients with a confirmed diagnosis of IBS on the basis of Rome IIIV with a control group were selected. Included studies were analyzed for risks of bias and publication bias. Clinical efficacy was assessed by comparing data on gastrointestinal symptoms reduction and psychological condition. A subgroup analysis was used to compare the effectiveness of group and individual hypnotherapy, as well as the number of sessions conducted. RESULTS. Nine studies (867 patients) were included in the final meta-analysis. Hypnotherapy was significantly more effective in reducing gastrointestinal symptoms in patients with IBS compared to controls (SMD=0.25 [95% CI 0.020.49], I2=53%, p=0.03), with positive effects persisting up to one year (SMD=0.34 [95% CI 0.070.60], p=0.01). Hypnotherapy resulted in an equalization of the psychological distress (MD=1.09 [95% CI from 1.27 to 3.44], p=0.37), but the results were not significant. Group hypnotherapy (SMD=0.35 [95% CI 0.010.70], p=0.05) and higher amount of hypnotherapy sessions during treatment (SMD=0.35 [95% CI 0.140.57], p=0.001) were more effective. CONCLUSION. Based on the results of this systematic review, it is fair to assume that the most effective use of hypnotherapy in patients with IBS, including those with therapy-resistant forms, is more than 7 sessions of group hypnotherapy more than once a week with a minimum session time of 45 minutes.
1 January 2022 in S.S. Korsakov Journal of Neurology and Psychiatry
To evaluate the effectiveness of low doses (25-75 mg/day) of quetiapine (Seroquel) in patients with bipolar affective disorders in a euthymic state with signs of impaired impulse control. The main criteria for patients' selection were as follows: both sex, diagnoses of bipolar affective disorders, remission (euthymic state), adult age (from 18 to 60 years old), stable basic therapy. The duration of the study was 6 weeks, a dose of quetiapine (Seroquel) varied from 25 to 75 mg. The examinations were carried out with the Barratt scale, computerized Go-No-Go and Balloon tests. The study group included 32 patients (11 men and 21 women), mean age 31.2±9.7 years (minimum 18, maximum 60 years). The changes in Barratt total score (p=0.000014, Wilcoxon test, effect size 0.48) and Balloon total earnings (p=0.03, Wilcoxon test, effect size 0.22) were statistically significant and reflected clinically significant improvement. The changes of the indices of the Go-No-Go test were not significant. The data of fMRI showed an increase in the connectivity of the cortex of the central and parietal tegmentum of the left hemisphere with other areas of the brain, which correlated with the changes in psychometric and test parameters. The results of the study showed that add-on of the low doses of quetiapine (Seroquel) significantly decreases impaired impulse control in remitted patients with bipolar affective disorders both in self-evaluation and in risk-taking experimental test. The drop of high level of impulsivity can improve the quality and stability of remission and reduce behavioral risks due to impaired impulse control.